Table 1 Clinical and biological characteristics of patients at admission

N = 124 patients

Age (Y)

32 ± 2.8

Gender (M/F)

5 / 119

 AN-R type

90 (73%)

 AN-BP type

34 (27%)

Duration of AN since diagnostic (Y)

7.9 ± 5.7

BMI

12.3 ± 2,5

HR (bpm)

61.6 ± 17.2

SBP (mm Hg)

99.2 ± 12

DBP (mmHg)

65.6 ± 10.6

 FFM (Kg)

28.8 ± 4.8

 FM (%)

8.8 ± 3.8

 FFMI (%)

10.8 ± 1.4

 QT interval (mm)

406 ± 54

 QTc interval (mm)

385 ± 31

 QT/QTc

1 ± 0.1

 Pericardial effusion

34 (27%)

 LVEF (%)

63 ± 10

 LV mass (g)

80 ± 22

 Albumin (38–52 g/l)

36.9 ± 7.1

 Transthyretin (0.21–0.45 g/l)

0.248 ± 0.102

 CRP (< 5 mg/l)

6.5 ± 23.7

 BNP (<  100 pg /l)

54 ± 70

 Potassium (3.7–4.7 mmol/l)

3.8 ± 0.6

 Calcium (2.12–2.52 mmol/l)

2.2 ± 0.1

 Phosphorus (0.8–1.45 mmol/l)

1.1 ± 0.3

 Magnesium (0.70–1.00 mmol/l)

0.8 ± 0,1

 Patients with Hypertransaminasemia^a

34 (27%)

 AST (15–37 UI/l)

137.6 ± 425.8

 ALT (12–78 UI/l)

170.1 ± 371.4

 Total Cholesterol (C) (3.00–6.00 mmol/l)

4.2 ± 1.4

 HDL-C (0.8–1.9 mmol/l)

1.8 ± 0.7

 LDL-C (< 4.1 mmol/l)

2.1 ± 1.1

 Total TG (< 1.7 mmol/l)

0.9 ± 0.7